English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO
    Live: Stock Market Live: Sensex @60,000: Are We Looking At A New Bull Run?
    you are here: HomeNewsBusinessMoneycontrol Research

    API export restriction: Takeaways for Indian pharma industry

    Anubhav Sahu
    March 05, 2020 / 07:39 PM IST
    API export restriction: Takeaways for Indian pharma industry

    PRO Only Highlights
    -      Quarterly performance largely backed by improved realisations
    -      Medium-term triggers China plus and protectionist measures for tyre industry
    -      Valuations not inexpensive; but improved medium-term outlook

    Highlights - 13 APIs & formulations kept under restricted list for exports - Impact would be more in terms of pricing than volumes - Pricing impact likely for Granules India, Aarti drugs, JB Chemicals and Anuh Pharma - Investors should position for companies having a broad portfolio The Directorate General of Foreign Trade has notified that 13 APIs (Active Pharmaceutical Ingredient) and its formulations are now under the restricted list for exports. This isn’t a blanket export ban—what it means is that exporters of these ingredients need...

    • PRO Panorama

      Moneycontrol Pro Panorama | View from atop the 60K peak

      Aug 18, 2022 / 04:41 PM IST

      In today’s edition of Moneycontrol Pro Panorama: Misuse of police, bright spots on recovery radar, the metal blues, green code for startups, politics behind freebie politics and more

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | Shaktikanta Das refuses to pivot 

      Aug 6, 2022 / 10:21 AM IST

      A look at the current macro readings is enough for the RBI governor not to budge and dilute his ‘withdrawal of accommodation’ stance

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers